A meeting next week here in San Francisco will feature leading researchers discussing “open” modes of collaborative discovery with a special emphasis on infectious diseases of the developing world.
Collaborative Drug Discovery, Gladstone Center for Translational Research, and the California Institute for Quantitative Biomedical Research (QB3) at the University of California San Francisco (UCSF) will be holding their first Annual Community Meeting on March 5, 12:30-7:00 pm, on the first floor of the Gladstone Institute Auditorium at the UCSF Mission Bay Campus. PLoS will also be in attendance and will be featuring a poster on PLoS Neglected Tropical Diseases.
* Christopher Lipinski, PhD, Pfizer, retired (Keynote presentation)
* James McKerrow, MD, PhD, Dept. of Pathology, QB3 – UCSF
* Matthew Bogyo, PhD, Dept. of Pathology, Stanford Medical School
* David Roos, PhD, Director Penn Genomics Institute, Univ. of Pennsylvania
* Andrej Sali, PhD, Dept. of Biopharmaceutical Sciences, QB3 – UCSF
* Anang Shelat, PhD, St. Jude Children’s Research Hospital
More about the meeting:
The future role of “open” collaborative drug discovery for research on the infectious diseases of the developing world will be discussed, along with related timely topics. A provocative global research project to speed up malaria drug discovery and the fight against drug resistance by web-sharing unpublished data will be presented. A panel will discuss global health research collaborations from the perspectives of academia, industry, and foundations. In addition to the above-mentioned panel and presentations, the meeting will include 16 posters, software demonstrations, and training for using the CDD Community Database.
If you are in the area, please attend this free meeting, and stop by to meet PLoS staff and learn more about open-access publishing and global health.